“ACOG’s withdrawal from ACIP is not a withdrawal from our commitment to advancing vaccine science or to protecting patients’ health and safety.” – ACOG President Steven J. Fleischman, MD

“A lot of our individuals are young, so we’ve seen this cancer being diagnosed during or after pregnancy, and often it gets labeled as hemorrhoids … but in hindsight, probably should have warranted attention earlier.” – Pashtoon Kasi, MD

“Given that studies project cases will increase by 38-54% and deaths by 68-71% by 2050, prevention through lifestyle modification becomes critically important.” – Amy Bremner, MD

“Endometriosis pain can be incredibly burdensome for women and girls, and we know that on top of that pain, many patients experience understandable frustration due to delays in care.” – ACOG President Steven J. Fleischman, MD

“Use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” — FDA Class II Recall Definition

The primary study outcome was a composite of serious bleeding events leading to hospitalization. Secondary study outcomes included composites of stroke or systemic embolism.